Stock Events

RetinalGenix Technologies 

$3.5
3
+$0+0% Tuesday 20:00

Statistics

Day High
3.5
Day Low
3.5
52W High
9
52W Low
3
Volume
451
Avg. Volume
0
Mkt Cap
62.25M
P/E Ratio
0
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RTGN. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
NovoCure
NVCR
Mkt Cap1.98B
NovoCure operates in the field of oncology and medical devices, similar to RetinalGenix's focus on innovative healthcare solutions.
Intuitive Surgical
ISRG
Mkt Cap161.39B
Intuitive Surgical develops, manufactures, and markets robotic products which compete in the medical device sector like RetinalGenix.
Medtronic
MDT
Mkt Cap101.91B
Medtronic is a major player in medical devices, directly competing with RetinalGenix in the healthcare equipment sector.
Abbott Laboratories
ABT
Mkt Cap177.49B
Abbott Laboratories offers medical devices and healthcare solutions, competing in similar markets as RetinalGenix.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific is involved in the development of medical devices, which places them in direct competition with RetinalGenix.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation specializes in medical technologies, including devices and equipment that compete with RetinalGenix's offerings.
Zimmer Biomet
ZBH
Mkt Cap22.73B
Zimmer Biomet Holdings operates in the musculoskeletal healthcare sector, competing with RetinalGenix in the broader medical device market.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson's medical device segment competes with RetinalGenix in providing comprehensive healthcare solutions.
Hologic
HOLX
Mkt Cap18.23B
Hologic focuses on medical devices for diagnostics, surgery, and women's health, areas that overlap with RetinalGenix's market.

About

RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Show more...
CEO
Country
US
ISIN
US76133Y1055

Listings

OTCM
US
RTGN